● VV-ECMO Circuit Assessment (Continuous)
| Parameter | Target / Normal | Action if Abnormal |
| Pump Speed (RPM) | 2000–3500 RPM (device specific) | If RPM high but flow low → assess for suction/hypovolaemia |
| Flow (L/min) | 4–6 L/min | If low: check volume, cannula position, increase RPM cautiously |
| Sweep Gas FiO₂ | Titrate — start 1.0, wean | Increase FiO₂ for hypoxia; assess oxygenator function |
| Sweep Gas Flow Rate | Titrate to PaCO₂ | Increase flow to reduce PaCO₂; decrease to raise PaCO₂ |
| Pre-membrane pO₂ | ~40–60 mmHg (venous) | Markedly low → high O₂ consumption, adjust support level |
| Post-membrane pO₂ | >400 mmHg on FiO₂ 1.0 | Drop >25% from baseline = oxygenator failure → prepare circuit change |
| Transmembrane Pressure | <50 mmHg gradient | Rising TMP = oxygenator clot → notify ECMO specialist |
| Circuit Colour | Post-membrane: bright red; Pre: dark | Post-membrane dark = oxygenator failure |
● Recirculation
Recirculation occurs when oxygenated blood returned to the venous system is immediately re-drained into the circuit before reaching the patient — reducing effective support.
Recognition
- Both drainage and return limbs appear similarly bright (oxygenated)
- Patient SpO₂ low despite high ECMO flow and good oxygenator function
- SaO₂ on drainage sample unexpectedly high (>75%)
- Recirculation fraction = (SrO₂ − SvO₂) / (SpO₂ − SvO₂)
Management
- Reposition cannulae — increase distance between tips
- Reduce ECMO flow temporarily
- Ensure adequate intravascular volume
- Consider position change (e.g., Trendelenburg)
- Imaging to confirm cannula positions (CXR, echo)
● Anticoagulation Management — VV-ECMO
UFH Protocol
- Unfractionated heparin (UFH) — continuous infusion
- aPTT target: 55–70 seconds
- Anti-Xa target: 0.3–0.5 units/mL
- ACT target: 180–200 seconds
- Monitor ACT every 4–6 hours
- aPTT or anti-Xa: 6-hourly until stable, then 12-hourly
Lower anticoagulation targets acceptable if active bleeding — discuss with ECMO team and haematology
HIT Surveillance & Management
- Monitor platelet count daily
- HIT suspect: platelet drop >50% from baseline, 5–10 days post-heparin
- Send HIT antibody (anti-PF4/heparin) ELISA
- If HIT suspected: stop all heparin immediately
- Switch to direct thrombin inhibitor: Argatroban
- Argatroban target: aPTT 45–80 seconds (institution specific)
- Bivalirudin: alternative — monitor aPTT or ECT
HIT on ECMO is life-threatening — rapid circuit thrombosis risk. Escalate immediately.
● SpO₂ Targets & Native Lung Ventilation
Oxygenation Targets — VV-ECMO
SpO₂ 88–95% is acceptable on VV-ECMO. Do not over-treat mild hypoxia — permissive hypoxaemia reduces lung injury.
- PaO₂ 55–80 mmHg acceptable
- Haemoglobin target: 10–12 g/dL (transfuse PRBC if below)
- Optimise ECMO flow before escalating ventilator settings
Lung Rest Ventilation Strategy
Goal: minimise ventilator-induced lung injury while ECMO supports gas exchange.
| Parameter | Lung Rest Target |
| Tidal Volume | 3–4 mL/kg IBW |
| Respiratory Rate | 10–15 breaths/min |
| PEEP | 10–15 cmH₂O |
| FiO₂ (vent) | 0.3–0.5 |
| Plateau Pressure | <25 cmH₂O |
● Haemodynamic Targets — VA-ECMO
| Parameter | Target | Clinical Note |
| MAP | 65–80 mmHg | Higher MAP may increase LV afterload — balance carefully |
| Heart Rate | 60–100 bpm | Tachycardia increases myocardial O₂ demand |
| CVP | 8–12 mmHg | Very high CVP → consider RV failure or fluid overload |
| SvO₂ (drainage line) | >65% | Low SvO₂ = inadequate O₂ delivery → increase flow or Hb |
| Lactate | Trend downward, target <2 mmol/L | Rising lactate = inadequate perfusion or ischaemia |
| Urine output | >0.5 mL/kg/hr | Oliguria = inadequate flow or AKI — consider RRT |
| ECMO Flow | 3–5 L/min | Titrate to above targets; avoid excessive flow causing LV distension |
● Arterial Line Monitoring — Harlequin Syndrome
Harlequin / North-South Syndrome: In femoral VA-ECMO — well-oxygenated ECMO blood (from femoral artery) competes with poorly oxygenated blood from native heart ejection. Upper body (brain, right arm) may receive hypoxic blood while lower body is well-oxygenated.
Dual Arterial Line Strategy
- Peripheral line: radial artery (right side preferred) — monitors native cardiac output oxygenation
- Central line: femoral or aortic — monitors ECMO circuit perfusion
- Compare SpO₂ from right hand vs lower limb
- If right hand SpO₂ < lower limb SpO₂ = Harlequin
Harlequin Management
- Optimise native lung ventilation (increase FiO₂, PEEP)
- Add venous drainage to jugular (VAV configuration)
- Increase ECMO flow to maximise retrograde oxygenated blood reaching arch
- Consider transition to central cannulation
- Monitor cerebral oximetry (NIRS) if available
● Cardiac Recovery Monitoring
Signs of Native Heart Recovery
- Improving pulsatility on arterial waveform — pulse pressure widening
- Aortic valve opening on echocardiogram
- Improving LVEF on serial echo
- Ability to reduce ECMO flow without haemodynamic deterioration
- Decreasing vasopressor requirements
- Improving lactate and SvO₂
Echocardiographic Assessment
- Daily TTE or TOE assessment on VA-ECMO
- LVEF measurement — target improvement to >20–25% before weaning trial
- Assess aortic valve opening — if not opening, LV distension risk
- LV end-diastolic diameter — increasing = distension
- Mitral regurgitation severity
- RV function assessment
ECMO weaning trial: stepwise reduction of flow under echo guidance with haemodynamic monitoring
● LV Distension — Recognition & Venting
VA-ECMO increases LV afterload (retrograde aortic flow). If native heart cannot eject adequately, LV distends → pulmonary oedema → lung haemorrhage. Requires urgent intervention.
Recognition
- Pulmonary oedema on CXR
- Increased PCWP / LAP
- Aortic valve not opening
- LV dilation on echo
- Falling SpO₂
LV Venting Options
- Impella — transaortic LV unloading device (preferred)
- IABP — intra-aortic balloon pump
- Atrial septostomy — blade/balloon septostomy
- Surgical LV vent (central ECMO)
Nursing Actions
- Escalate to ECMO specialist immediately
- Prepare for bedside echo
- Have diuretics ready (if residual renal function)
- Document CXR findings and trends
- Monitor SpO₂ continuously
● Lower Limb Ischaemia — Distal Perfusion Cannula
Femoral arterial return cannula may obstruct distal perfusion to the leg — limb ischaemia risk. Distal perfusion cannula (DPC) inserted into superficial femoral artery is standard of care.
Hourly Limb Assessment — VA-ECMO
- Distal pulses: dorsalis pedis, posterior tibial — Doppler if not palpable
- Capillary refill time: <2 seconds normal
- Temperature: compare both limbs — cool = ischaemia
- Colour: pallor, mottling, cyanosis
- SpO₂ probe on great toe of cannulated limb
- Pain/paraesthesia in awake patients
- Document findings hourly — escalate immediately if deteriorating
DPC Management
- Confirm DPC flow — visible pulsatile blood flow
- DPC connected to ECMO circuit return limb via Y-connector
- Keep DPC site clean and patent
- Compartment syndrome: hard, tense calf → escalate urgently
- Rhabdomyolysis: CK, myoglobinuria monitoring
Any new signs of limb ischaemia = immediate ECMO specialist notification. Irreversible damage within hours.
● ECMO Centres in the GCC
| Centre | Country | ECMO Programme Highlights |
| King Faisal Specialist Hospital & Research Centre | Saudi Arabia (Riyadh) | Major adult and paediatric ECMO programme; significant cardiac and respiratory ECMO volume; ECMO for post-cardiac surgery; active research programme |
| Cleveland Clinic Abu Dhabi | UAE (Abu Dhabi) | Advanced cardiac surgery programme; VA and VV ECMO; ECMO for cardiac transplant bridge; trained specialist nursing team |
| Hamad Medical Corporation (HMC) | Qatar (Doha) | National ECMO programme; gained significant experience during COVID-19; ECMO transport capability; paediatric ECMO |
| King Abdullah Medical City (KAMC) | Saudi Arabia (Makkah) | ECMO during Hajj season — unique context of mass gathering medicine |
| King Fahad Medical City | Saudi Arabia (Riyadh) | Paediatric ECMO focus; congenital heart disease post-repair support |
| Oman and Kuwait tertiary centres | Oman, Kuwait | Developing ECMO programmes; referral to Saudi Arabia/UAE for complex cases |
● ECMO & Infectious Disease Experience — GCC
MERS-CoV ECMO Experience
- Middle East Respiratory Syndrome Coronavirus — endemic in Arabian Peninsula
- Severe MERS-CoV ARDS: P/F ratio <80 — VV-ECMO indication
- Saudi Arabia accumulated significant VV-ECMO experience for MERS
- Outcomes data published from KFSHRC and other Saudi centres
- Infection control: ECMO for MERS required full PPE — N95, gown, gloves, eye protection
- Circuit management with aerosolisation precautions
COVID-19 ECMO Experience
- GCC hospitals established/expanded ECMO programmes during COVID-19 pandemic (2020–2022)
- Qatar (HMC) and UAE treated international patients on ECMO
- ELSO COVID-19 guidelines followed across GCC
- VV-ECMO for COVID-ARDS: P/F <80 despite optimal proning and ventilation
- Extended ECMO runs (weeks to months) — unique nursing challenges
- Nursing staff rapidly trained and upskilled during pandemic
● ECMO Transport in GCC
Inter-hospital ECMO transport (mobile ECMO) allows patients to be cannulated at referring hospital and transported on ECMO to specialist centre — expanding access across GCC.
Mobile ECMO Team Composition
- ECMO specialist physician (intensivist/cardiac surgeon)
- ECMO specialist nurse
- Perfusionist or ECMO technician
- Additional transport nurse/paramedic
- Transport: ground ambulance (short distance), helicopter or fixed-wing aircraft (inter-emirate/cross-border)
Transport Nursing Considerations
- Transport ECMO console — battery-powered, certified for air transport
- Adequate drug and blood product supply for transport duration
- Secure all connections before movement
- Ventilator transport settings — anticipate vibration effects
- Communication with receiving team pre-arrival
- Documentation: ECMO parameters logged throughout transport
● ECMO Nurse Specialist Training — GCC Standards
ELSO Guidelines — GCC Adoption
- Extracorporeal Life Support Organisation (ELSO) — international standards body
- GCC centres following ELSO guidelines for circuit management, anticoagulation, weaning
- ELSO registry participation — data submission from major GCC centres
- ELSO training courses offered at GCC centres
Nurse Specialist Training Pathway
- ICU registered nurse with ≥2 years critical care experience
- ECMO theory training: circuit physics, pathophysiology, pharmacology
- Simulator training: circuit management, emergency scenarios
- Supervised clinical practice: minimum case numbers
- Competency assessment: annual recertification
- ECMO Coordinator role in major GCC centres
● Ethical & Cultural Considerations in GCC ECMO
Withdrawal of ECMO Support
Withdrawal of life-sustaining treatment in GCC follows Islamic bioethical principles — requires careful, respectful communication with families.
- Islamic bioethics: preservation of life is paramount; extraordinary measures not obligatory if futile
- Fatwa (religious ruling) may be sought by family in difficult decisions
- Family consensus preferred — extended family may be involved
- Hospital ethics committee involvement for complex cases
- Palliative care team integration — increasing across GCC
- Documentation of decision-making process essential
Religious & Family Support in ECMO ICU
- Prayer: Adhan (call to prayer) and Quranic recitation — important comfort measure for Muslim patients
- Qibla (direction of Mecca) orientation for bed placement where feasible
- Family visitation: infection control requires limiting visitors, but flexibility for dying patients
- Female patients: maintain modesty during ECMO care procedures
- Ramadan: fasting exempted for critically ill patients — but family may wish to participate in care during Iftar/Suhoor times
- Hospital chaplaincy/Imam service available in all major GCC hospitals
● Paediatric ECMO in GCC
Indications
- Congenital heart disease post-operative repair — most common indication in GCC tertiary paediatric cardiac centres
- Failure to wean from cardiopulmonary bypass
- Post-operative low cardiac output syndrome
- Neonatal respiratory failure (CDH, MAS, PPHN)
- Paediatric myocarditis
- Paediatric ARDS (including MERS-CoV and COVID-19)
Paediatric Nursing Considerations
- Weight-based flow calculations (target: 100–150 mL/kg/min neonates)
- Blood prime circuit for neonates/small children — reduces haemodilution
- Temperature regulation more critical — neonates hypothermia risk
- Developmental care: touch, voice, gentle stimulation within circuit limits
- Family presence: parents at bedside — ECMO education essential
- Play therapy and psychological support for older children on ECMO